Why Avantax Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.